Two euro CLO prints, and the constraint is collateral

Royal London Asset Management priced its third CLO alongside Morgan Stanley and PGIM contracted Jefferies to arrange Dryden 134 Euro CLO, closing out the week's European primary issuance, Creditflux reported, though neither deal's size, spread, or tranching is in the coverage. The two mandates show the shape of the euro CLO bid in 2026: managers whose main business sits elsewhere in credit using the structure as term funding, and banks happy to arrange the paper while the window is open.

The Royal London deal is the more informative of the two: a first CLO proves a manager can get a deal away, while a third says something about intent, because repeat issuance is how a manager converts a single print into a shelf investors can underwrite across vintages. Whether that reading holds depends on terms the coverage does not carry, but the deal count is itself a disclosure — third-time issuers are what make a primary market deep enough to absorb a heavy pipeline, and a heavy pipeline is what the euro market has.

PGIM arrives from the other direction: Dryden 134 Euro CLO carries a number that implies a series long enough for the 134th iteration to be routine, though the coverage does not describe the program. The mandate shows a manager extending an existing shelf while building elsewhere in credit — PGIM's move to full ownership of Deerpath in August was the equity side of that construction, control of an originator, and a European CLO is the funding side. Reading the Deerpath deal and the Dryden mandate as one strategy rather than two is the only reading that explains why the same group wants both in the same year.

Both deals land against a pipeline this publication sized a week ago at EUR60bn, two-thirds of it tied to M&A, and that supply is the feedstock for new-issue CLOs: without loans to bundle, an arranger mandate is just a mandate. The earlier point stands that deal supply helps unitranche volume and hurts spread, with the second effect the one that sticks, and CLO issuance sits on the other side of that dynamic. The more M&A-driven paper there is to finance, the more collateral exists for CLOs to buy — but the more competition there is for every loan that reaches syndication, which is exactly how a pipeline becomes a pricing problem for the very managers who need it as inventory.

The reset channel is the other half of the picture, and it has become private credit's funding valve: managers reset seasoned deals and print static CLOs from existing portfolios because CLO resets make funding cheaper and push out maturities. The gate on that channel tightened when Carlyle's cheque ended the free-reset era, and every 2018-vintage CLO now has to prove it can raise equity rather than simply extend, while a new issue clears a higher bar again, since the equity has to be placed against a portfolio that does not yet exist. On that measure the week is a good one for the primary market: two managers, two banks, two deals, with the equity placement evidently not the obstacle the reset debate has made it out to be for seasoned deals.

European CLO liability demand is not the binding constraint on this market, and has not been for most of 2026; collateral is. Managers printing new paper into that condition are buying funding certainty ahead of a squeeze, not chasing a spread that the loan market will hand back within a quarter. The ones with a shelf to protect — Royal London on its third deal, PGIM somewhere past its hundredth — have the most reason to move first and the least reason to wait for better terms that a heavier pipeline makes less likely, not more. A manager issuing a debut would be taking the opposite bet; a repeat issuer is not.

None of this should be read as a claim that the euro CLO window is wide. Two deals closing out a week is a functioning market, not a hot one, and the coverage gives no print levels to test that against. The two arranging banks here are Morgan Stanley and Jefferies, which says something about how far the mandate list now reaches beyond the handful of dealers that dominated the structure's earlier euro years, though the coverage does not itself make that case.

The test arrives with Royal London's fourth deal. If it prices while the EUR60bn pipeline is still clearing, the shelf thesis holds and Europe has another repeat issuer whose paper buyers can underwrite without re-learning the name each time. If the window narrows first, this week's prints will read as a market taking the deals it could get — and the collateral question will have answered itself the hard way.